Sign inJoin waitlistJoin the waitlist

Ryan D'Souza

Professor of Anesthesiology · Mayo Clinic College of Medicine and Science

Credentials: · · · · · ·

History

Mayo Clinic College of Medicine and Science
Present

Pain Medicine
Mayo Clinic College of Medicine and Science
2020–2021
Anesthesiology
Mayo Clinic College of Medicine and Science
2016–2020
University of Colorado School of Medicine
2012–2016

Research

Danon disease: clinical features, evaluation, and management
Review · Circulation Heart Failure · 2014 · First of 8 authors · 169 citations
Ebola virus and severe acute respiratory syndrome coronavirus display late cell entry kinetics: evidence that transport to NPC1+ endolysosomes is a rate-defining step
Journal of Virology · 2015 · 93 citations
Evidence-Based Clinical Guidelines from the American Society of Pain and Neuroscience for the Use of Implantable Peripheral Nerve Stimulation in the Treatment of Chronic Pain
Review · Journal of Pain Research · 2022 · 87 citations

Nasir Hussain
58 papers · 9 as a fellow
Jon Hagedorn
28 papers
JK
Jay Karri
26 papers · 9 as a fellow
Alaa Abd-Elsayed
19 papers
Timothy Deer
17 papers
Natalie Strand
16 papers
Fransoua Her
15 papers · 6 as a fellow
Vwaire Orhurhu
15 papers · 1 as a resident
Saba Javed
14 papers · 4 as a fellow
Dawood Sayed
13 papers
Tristan Weaver
12 papers
BL
Brendan Langford
9 papers · 9 as a resident

Clinical trials

Erector Spinae Plane Block Versus Trigger Point Injection for Chronic Thoracic Myofascial Pain
Principal investigator · Recruiting · Phase 4
Mayo Clinic
2026–2029
Optimal Duration of Spinal Cord Stimulation Trial Procedure: Length and Diagnostic Accuracy
Principal investigator · Enrolling by invitation
University of Maryland, Baltimore
2023–2026
Assessing Effect of Spinal Cord Stimulation on Pain and Quality of Life With Chemotherapy-Induced Peripheral Neuropathy
Principal investigator · Recruiting
Mayo Clinic
2022–2028
A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease
Site PI · Recruiting · Phase 3
DiscGenics, Inc.
2025–2028